Clinical Trial Update: Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reduced-dose intensity-modulated radiation therapy with or without cisplatin in advanced oropharyngeal squamous cell carcinoma; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Squamous Cell Carcinoma
• Tongue Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: NRG Oncology | Conditions: Stage III Oropharyngeal Squamous Cell Carcinoma, Stage IVA Oropharyngeal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-08-12